Dicyclomine Hydrochloride Capsules recall
FDA recall D-0733-2026 · initiated Jul 23, 2026
Aurobindo Pharma USA Inc recalled Dicyclomine Hydrochloride Capsules in Jul 2026 — an FDA Class II recall (D-0733-2026) because shortfill; reports of empty capsules.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
shortfill; reports of empty capsules.
Another quality failure
A quality failure that does not fit the categories above.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 6,408 bottles distributed to market
Details
- Product
- Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
- Recalling company
- Aurobindo Pharma Limited
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Jul 23, 2026
- FDA report date
- Aug 12, 2026
Frequently asked
- Was Dicyclomine Hydrochloride Capsules recalled?
- Aurobindo Pharma USA Inc recalled Dicyclomine Hydrochloride Capsules in Jul 2026 — an FDA Class II recall (D-0733-2026) because shortfill; reports of empty capsules. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Dicyclomine Hydrochloride Capsules recalled?
- Per the FDA enforcement record, the reason for recall D-0733-2026 was: shortfill; reports of empty capsules.
- Is a recalled Dicyclomine Hydrochloride Capsules dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Dicyclomine Hydrochloride Capsules are affected?
- Distributed: US Nationwide.. The recall covers these lots — Batch # DMC125018A, Exp Date: 07/2027.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0733-2026.